Clinical Trial to Research Breast Cancer Hair Loss Prevention

Researchers from the Lester and Sue Smith Breast Center at Baylor College of Medicine are recruiting newly diagnosed breast cancer patients to participate in a new clinical trial testing the safety and efficacy of an investigational scalp cooling device to prevent hair loss associated with chemotherapy.

Participants interested in enrolling in the study must:

Have a new diagnosis of breast cancer stage 1 or 2 and under the age of 70

Plan to undergo neoadjuvant or adjuvant chemotherapy with curative intent

Chemotherapy must be planned for at least four cycles of full-dose anthracycline or taxane based chemotherapy regimen, defined as one of the following chemotherapy regimens:

Adriamycin 60mg/m2 with cyclophosphamide 600mg/m2

Epirubicin 90-100mg/m2 with cyclophosphamide 600mg/m2

Paclitaxel 80mg-90/m2 weekly (every three weeks constitute a cycle), or 175 mg/m2 every 2-3 weeks as a single agent

Docetaxel 100mg/m2 as a single agent

Docetaxel 75mg/m2 with cyclophosphamide 600mg/m2

Docetaxel 75mg/m2 with carboplatin AUC of 6 and traztuzumab at standard doses

Study participants will be followed until 2-4 weeks after completion of chemotherapy when the final alopecia (hair loss) assessment will occur and the questionnaires will be administered. For more information or to enroll, please call Afife Batarse at 713-798-1911.

We are hopeful that there will be a breakthrough in preventing hair loss for cancer patients in the near future.  In the meantime, our team at Ricky Knowles Hair & Wellness specializes in creating a private and supportive environment for our clients.  If you are looking for a hair duplication solution while you are undergoing cancer treatment, please call us at 713-623-4247.